1. Home
  2. OKYO

OKYO

OKYO Pharma Limited

Logo OKYO Pharma Limited

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Founded: 2007 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 51.0M IPO Year: 2022
Target Price: $7.00 AVG Volume (30 days): 172.8K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.61 EPS Growth: N/A
52 Week Low/High: $0.92 - $3.25 Next Earning Date: 04-19-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: